Werewolf Therapeutics, Inc. HOWL 深 滬
交易中 09-20 14:45:46 美东时间
2.25
-0.150
-6.25%
華盛通- 最 高2.38
- 今 開2.38
- 成交量 12.43万股
- 最 低 2.18
- 昨 收 2.40
- 總市值 9615.87万
- 52周最高 8.1939
- 市盈率 靜 --
- 換手率 0.29%
- 52周最低 1.5735
- 委 比 -95.31%
- 總股本 4273.72万
- 歷史最高 23.99
- 量 比 1.29
- 振 幅 8.33%
- 歷史最低 1.39
- 每 手 1
- 風險率 1.72%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多快讯 | Werewolf Therapeutics公司：Leerink合作伙伴将目标价下调至13美元，原为15美元。
Werewolf Therapeutics Inc : Leerink Partners Cuts Target Price to $13 From $15
08-19 18:26
快讯 | 狼人治疗：截至6月30日的现金及现金等价物足以支持至少2026年Q1的运营费用和资本支出要求。
Werewolf Therapeutics: Cash & Cash Equivalents as of June 30 Enough to Fund...
08-08 19:28
快讯 | Werewolf Therapeutics发布2024年第二季度财务业绩和业务更新
Werewolf Therapeutics Reports Second Quarter 2024 Financial Results and Provide...
08-08 19:05
JMP Securities Reiterates Market Outperform on Werewolf Therapeutics, Maintains $12 Price Target
JMP Securities analyst Reni Benjamin reiterates Werewolf Therapeutics (NASDAQ:HOWL) with a Market Outperform and maintains $12 price target.
06-27 00:05
Where Werewolf Therapeutics Stands With Analysts
Ratings for Werewolf Therapeutics (NASDAQ:HOWL) were provided by 7 analysts in ...
06-26 20:01
快讯 | 狼人治疗：结果显示临床活性的令人鼓舞的信号
Werewolf Therapeutics: Results Showed Encouraging Signals of Clinical Activity
06-25 19:03
快讯 | Werewolf Therapeutics从其正在进行的Wtx-330在晚期或转移性实体瘤或非何杰金淋巴瘤患者中的1期临床试验中突出了初始安全性和疗效数据。
Werewolf Therapeutics Highlights Initial Safety and Efficacy Data From Its Ongo...
06-25 19:00
Analysts Offer Insights on Healthcare Companies: Ibio (IBIO) and Werewolf Therapeutics (HOWL)
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts jus...
06-04 03:40
Werewolf Therapeutics’ Promising WTX-124 Clinical Trial Outcomes
The latest announcement is out from Werewolf Therapeutics (HOWL). Werewolf Ther...
06-03 20:55
Werewolf Therapeutics：Wtx-124 被证明具有临床活性患者总体耐受性良好
Werewolf Therapeutics：Wtx-124 被证明具有临床活性患者总体耐受性良好
06-01 21:03
